Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04594733 · ClinicalTrials.gov registry record · Phase 1
The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT04594733 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 14 participants.
The verdict
NCT04594733, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
Evaluation of the effect of combinatorial treatment of fibromyalgia patients (standard of care + minocycline + N-acetylcysteine (NAC) relative to standard of care on subjective pain measurement Revised Fibromyalgia Impact Questionnaire (FIQR).
Interventions
- DRUG minocycline (200 mg daily) and NAC (1200 mg daily) followed by placebo
- DRUG Placebo followed by minocycline (200 mg daily) and NAC (1200 mg daily)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-12-06 |
| Est. Completion | 2022-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04594733
The ClinicalTrials.gov registry entry for NCT04594733 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which minocycline (200 mg daily) and NAC (1200 mg daily) followed by placebo is the first listed.
NCT04594733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04594733 about?
NCT04594733 is a clinical study titled "The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia". Evaluation of the effect of combinatorial treatment of fibromyalgia patients (standard of care + minocycline + N-acetylcysteine (NAC) relative to standard of care on subjective pain measurement Revised Fibromyalgia Impact Questionnaire (FIQR).
What is the current status of trial NCT04594733?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2021-12-06. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT04594733?
The interventions under investigation include: minocycline (200 mg daily) and NAC (1200 mg daily) followed by placebo (DRUG), Placebo followed by minocycline (200 mg daily) and NAC (1200 mg daily) (DRUG).
Who is sponsoring clinical trial NCT04594733?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.